What are they doing?

Since 2014, they have spent six years and more than 40 million dollars. They said they were always screening their promising compoud collections and negotiating with FDA and other authorities. To date, they still have the only one chip on the table. They announced one successful P1 clinical trial but interestingly the announcement was classified shyly as a non price sensitive one. In 2016, some of you were still satisfied with their achievements. In 2018, most amateur scientists and analysts cleared their holdings and ran away. What will happen in 2020? I hope the company can bring us a better future.